ACADIA Pharmaceuticals Inc. (ACAD) by event type
ACAD moves most on analyst downgrades — a median of +1.33% at 30 minutes across 21 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ACAD overview →
How ACAD reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,306 of 2,717 | 32 | +0.02% | 50% | -0.23% |
| Analyst downgrades 66 of 2,603 | 21 | +1.33% | 67% | +0.88% |
| Coverage initiations 1,824 of 2,283 | 28 | -0.38% | 36% | -0.02% |
| Rating reiterations 2,575 of 3,522 | 164 | -0.10% | 44% | -0.04% |
| Price-target raises 1,555 of 1,790 | 35 | -0.19% | 40% | +0.10% |
| Price-target cuts 1,430 of 1,527 | 27 | -0.42% | 37% | -0.33% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how ACAD usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · ACAD overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kazia Therapeutics Limited - American Depositary Shares (KZIA) | 393 | -1.07% | 34% |
| OHR PHARMACEUTICALS (OHRP) | 393 | 0.00% | 48% |
| BioXcel Therapeutics, Inc. (BTAI) | 392 | -0.75% | 41% |
| Karyopharm Therapeutics Inc. (KPTI) | 392 | -0.45% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.